SCHEMBL23023643

SCHEMBL23023643

O=C(O)c1cc(Cc2ccccc2)n(Cc2ccccc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY14 Q15391 2/20 0.51
▸ MARS1 P56192 2/20 0.51
▸ HDAC3 O15379 1/20 0.48
▸ HDAC4 P56524 1/20 0.48
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC7 Q8WUI4 1/20 0.48
▸ HDAC2 Q92769 1/20 0.48
▸ HDAC10 Q969S8 1/20 0.48
▸ HDAC11 Q96DB2 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ HDAC6 Q9UBN7 1/20 0.48
▸ HDAC9 Q9UKV0 1/20 0.48
▸ HDAC5 Q9UQL6 1/20 0.48
▸ NCOR2 Q9Y618 1/20 0.48
▸ MALT1 Q9UDY8 1/20 0.47
▸ GRN P28799 2/20 0.47
▸ SORT1 Q99523 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31130367 0.88 SLC16A3 (0.61) P2RY14MARS1POLBSLC16A3SLC16A1
SCHEMBL1739296 0.86 MARS1 (0.45) P2RY14MARS1MALT1GRNSORT1
SCHEMBL2455065 0.81 GRN (0.64) P2RY14MARS1MALT1GRNSORT1
SCHEMBL15056101 0.81 P2RY14 (0.53) P2RY14MARS1MALT1GRNSORT1
SCHEMBL27847464 0.80 P2RY14 (0.53) P2RY14MARS1MALT1GRNSORT1
SCHEMBL1137143 0.79 PTGER1 (0.59) P2RY14POLBMEN1KMT2APTGER1
SCHEMBL24131122 0.79 RIPK1 (0.49) P2RY14GRNSORT1HCAR2
SCHEMBL26596756 0.79 P2RY14 (0.52) P2RY14MARS1MALT1GRNSORT1
SCHEMBL17611006 0.76 P2RY14 (0.52) P2RY14MARS1MALT1GRNSORT1
SCHEMBL20050048 0.76 PTGER1 (0.53) P2RY14PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10934299-B2 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors VALO EARLY DISCOVERY, INC. (US) 2021-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934299-B2 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors USP7, UBA7, UBXN1 P2RY14 2481/4885MARS1 1556/4885HDAC3 2543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback